Patent · US Active

Methods of administering 3,4-diaminopyridine

US11274332B2 · kind B2 · utility

2Cited by
8References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 15, 2021
Grant dateMar 15, 2022
Priority date—
Expiry dateOct 15, 2041

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are methods of determining NAT acetylation status of a subject with a 3,4-DAP-sensitive disease, methods of selecting a dose of 3,4-DAP or a pharmaceutically acceptable salt thereof adjusted to a subject's acetylation status, methods of administering 3,4-diaminopyridine or a pharmaceutically acceptable salt thereof to a patient in need thereof, and methods of treating 3,4-DAP sensitive diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.